Type II Collagen Market is set to reach US$ 2.14 billion by 2032, North America leads the market with 39% market share.

Type II Collagen Market reached US$ 1.31 billion in 2024 and is expected to reach US$ 2.14 billion by 2032, growing at a CAGR of 6.30% during the forecast period 2025-2032.

Type II Collagen is a specialized structural protein supporting joint cartilage integrity, mobility, and shock absorption, widely used in nutraceuticals and therapies targeting arthritis management and joint health.

DataM Intelligence unveils its latest report on the " Type II Collagen Market size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/type-ii-collagen-market?prtk

United States: Key Industry Developments ( 2025)

✅ November 2025: Bioiberica presented new clinical evidence showing low-dose undenatured Type II collagen (Collavant n2) supports cartilage health and reduces cartilage breakdown, unlocking opportunities for innovative joint-health formulations.

✅ October 2025: U.S. supplement manufacturers expanded direct-to-consumer distribution of Type II collagen products, meeting growing demand from aging and active lifestyle consumers for joint mobility and wellness solutions.

✅ September 2025: Several U.S. biotech and sports/orthopedic clinics initiated collaborative studies evaluating undenatured Type II collagen's role in post-exercise recovery and cartilage repair for adults and seniors.

✅ August 2025: Innovation trends in the U.S. highlighted edible Type II collagen functional beverages and daily-use joint health formats aimed at convenience and sustained consumption.

Asia Pacific / Japan: Key Industry Developments (2025)

✅ October 2025: Nippon CellTech launched Collexin-J, a next-generation Type II collagen supplement developed via proprietary fermentation to improve bioavailability and reduce inflammation, now rolling out in Tokyo pharmacies.

✅ September 2025: Nippi Collagen introduced a new marine-derived Type II collagen supplement tailored to support cartilage regeneration, joint flexibility, and mobility, especially for Japan's aging wellness consumers.

✅ September 2025: Major Japanese supplement firms reported increased sales and marketing efforts for Type II collagen products, driving uptake among older adults by linking collagen intake with joint health benefits.

📌 Type II Collagen Market 2025-26 M&A Deals
→ In December 2025, Greenvit acquired a majority stake in Synkol, a Polish specialist in type II chicken-sternal collagen production (HYACOLL brand), aiming to expand Greenvit's nutraceutical ingredient portfolio focused on joint, bone and mobility health.

→ In December 2025, Darling Ingredients and Tessenderlo Group signed a definitive agreement to form a new collagen joint venture (Nextida) by combining Darling's Rousselot collagen business with Tessenderlo's PB Leiner segment. Under the deal, Darling Ingredients will hold 85% ownership and Tessenderlo 15%, creating a company with US $1.5 billion expected annual revenue focused on collagen and gelatin health, wellness, and nutrition products.

→ In May 2025, Darling Ingredients and Tessenderlo Group agreed to form the Nextida company - a strategic joint venture combining Rousselot and PB Leiner's collagen/gelatin assets into a new global collagen player, with Darling holding 85% and Tessenderlo 15% and US $1.5 billion anticipated revenue base.

Type II Collagen Market Drivers:-
⏩ One of the most compelling growth stories in the Type II Collagen market is tied to global demographic change. As populations age, joint disorders such as osteoarthritis and rheumatoid arthritis are becoming more prevalent, pushing consumers toward preventive and supportive nutritional solutions.

⏩ Athletes and fitness enthusiasts increasingly demand supplements that support joint strength and recovery, with Type II collagen being recognized for its role in cartilage repair and flexibility.

⏩ This trend extends into sports nutrition and functional food markets, with collagen becoming a key ingredient in products targeting performance and injury prevention.

⏩ There is a growing consumer preference for natural and safe ingredients, which boosts the appeal of Type II collagen over synthetic alternatives.

⏩ Educated consumers influenced by healthcare professionals, clinical evidence, and social media wellness narratives - increasingly adopt collagen supplements as part of daily preventive health routines.

⏩ Improved collagen extraction and purification processes enhance bioavailability and consumer trust, facilitating broader adoption.

⏩ Formulators are incorporating Type II collagen into functional foods, beverages, and nutraceutical blends, expanding use cases and consumption occasions.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=type-ii-collagen-market?ptk

Type II Collagen Major Players:-
BioCell Technology, LLC, Vital Proteins, Rousselot, DSM-Firmenich, Chondrex, Inc., Titan Biotech Ltd., Takara Bio Inc., KOKEN CO., LTD., REPROCELL Inc. and Lonza Group.

Key players highlights:-
Rousselot - A leading global collagen manufacturer with strong presence in Type II collagen applications, holding an estimated ~15 % share in the broader collagen/peptide market.
Renowned for high-quality extraction technologies and a broad product range for nutraceutical and pharmaceutical uses.

Vital Proteins (Nestlé Health Science) - A major consumer-brand focused on collagen supplements, with ~10 % market share in the collagen peptide segment.
Drives growth through lifestyle branding and diversified product portfolio targeting joint and beauty wellness.

BioCell Technology, LLC - Known for its patented BioCell Collagen® ingredient, with a smaller ~3 % share in the collagen peptide market.
Focuses on clinically backed formulations blended for joint, skin, and sports nutrition products.

Lonza Group (via InterHealth Nutraceuticals / UC-II) - Key player in undenatured Type II collagen (UC-II) with significant adoption in joint health segments (share not individually published).
Combines clinical science and global distribution to expand Type II collagen ingredient presence worldwide.

DSM-Firmenich - A major nutrition and specialty ingredients company with a growing role in collagen solutions (precise Type II share not publicly available).
Leverages broad nutraceutical capabilities after the DSM and Firmenich merger to support innovation across health markets.

Type II Collagen Regional Highlights

North America
Largest regional share at 39% of the global Type II collagen market in 2024.
Growth driven by high consumer awareness, strong nutraceutical infrastructure, and aging populations.
Steady expansion with product innovation and robust e-commerce/diatary supplement channels.

Europe
Second-largest market 29% of global share in 2024.
Growth supported by preventive healthcare trends, favorable regulations, and R&D investments.
Consumers highly interested in natural, clean-label collagen products.

Asia Pacific
Smaller current share but fastest-growing region with strong CAGRs 11%+ forecast.
Expansion fueled by rising health awareness, disposable incomes, and urbanization.
Rapid e-commerce growth and Western dietary influence boosting market penetration.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/type-ii-collagen-market?ptk

Type II Collagen market segmentation :

The Type II Collagen Market is segmented by form, source, and application. By form, it includes powders, capsules, tablets, and liquids, catering to diverse consumption preferences. By source, it is derived mainly from chicken, bovine, marine, and other animal sources, influencing bioavailability and acceptance. By application, it is used across diatary supplements, pharmaceuticals, and functional foods, driven by growing demand for joint health and mobility support.

Q1: What factors are driving growth in the Type II Collagen Market?
Rising prevalence of joint disorders, aging population, and increasing demand for nutraceutical and orthopedic applications.

Q2: Which applications dominate the Type II Collagen Market?
Diatary supplements lead the market, followed by pharmaceutical formulations and medical nutrition products.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.